MyAverix Finance
LSE · Healthcare
Provexis plc (PXS)
Drug Manufacturers - Specialty & Generic
Provexis plc (PXS) is listed on LSE in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-19, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for PXS
Provexis plc (PXS) — FAQ
What is PXS's P/E ratio?
The price-to-earnings (P/E) ratio for Provexis plc (PXS) is 18.00 (data as of 2026-05-19).
Does Provexis plc pay a dividend?
Dividend yield is not available in the current snapshot for Provexis plc (PXS). Check the MyAverix Finance app for the latest dividend data.
What sector is Provexis plc in?
Provexis plc (PXS) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is PXS listed on?
PXS is listed on LSE.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.